EPIX

ESSA Pharma Inc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website essapharma.com
Employees(FY) 50
ISIN CA29668H7085

Performance

+4.82%

1W

-19.57%

1M

-36.71%

3M

+31.9%

6M

+2.12%

YTD

+130.82%

1Y

Profile

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Advanced Technical Analysis

Technical Analysis of EPIX 2024-05-03

Overview:

In analyzing the technical indicators for EPIX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day MA has been fluctuating around the actual closing pri...

See more ...

Recent News & Updates

2024-04-08 20:00
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference(Prnewswire)
2024-03-07 07:13
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS(Prnewswire)
2024-02-26 00:14
12 $10 Stocks That Will Triple(Yahoo Finance)
2024-02-13 15:35
ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results(Yahoo Finance)
2024-02-12 18:25
ESSA Pharma: Fiscal Q1 Earnings Snapshot(Yahoo Finance)
2024-02-12 18:00
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023(Yahoo Finance)
2024-02-07 20:47
ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares(GuruFocus.com)
2024-02-06 08:00
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference(PR Newswire)
2024-02-05 19:00
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference(Prnewswire)
2024-01-26 05:36
EPIX: Updated Data for Phase 1 Trial of Masofaniten Shows 63% of Patients Achieved PSA <0.2 ng/mL…(Zacks Small Cap Research)
2024-01-25 10:00
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium(CNW Group)
2024-01-22 07:16
ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains(Simply Wall St.)
2023-12-21 16:13
These Stocks under $10 Are Poised To Explode(Insider Monkey)
2023-12-20 08:23
EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…(Zacks Small Cap Research)
2023-12-12 09:12
ESSA Pharma Inc (EPIX) Reports Fiscal Q4 and Full-Year Earnings, Advances in Prostate Cancer ...(GuruFocus.com)
2023-12-12 07:20
ESSA Pharma: Fiscal Q4 Earnings Snapshot(Associated Press Finance)
2023-12-12 07:00
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023(CNW Group)
2023-12-11 23:03
EPIX Stock Earnings: ESSA Pharma Beats EPS for Q4 2023(Investorplace)
2023-12-11 18:00
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023(Prnewswire)
2023-12-11 05:17
Bullish ESSA Pharma Insiders Loaded Up On US$1.19m Of Stock(Simply Wall St.)
2023-11-23 11:05
Director Franklin Berger Bolsters Position in ESSA Pharma Inc with Purchase of 23,259 Shares(GuruFocus.com)
2023-11-21 08:00
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference(PR Newswire)
2023-11-20 19:00
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference(Prnewswire)
2023-11-07 19:00
ESSA Pharma to Present at the Jefferies London Healthcare Conference(Prnewswire)
2023-11-06 04:51
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement(Prnewswire)
2023-10-29 22:59
EPIX: Dose Escalation Data for Combination of Masofaniten (EPI-7386) and Enzalutamide Presented at PCF Retreat(Yahoo Finance)
2023-10-26 05:41
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat(Yahoo Finance)
2023-10-20 21:00
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congress(Yahoo Finance)
2023-09-17 19:00
ESSA Pharma Announces Initiation of Phase 2 Study Evaluating Masofaniten (EPI-7386) in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer(Yahoo Finance)
2023-08-30 19:00
ESSA Pharma Insiders Establish Automatic Securities Disposition Plans(Yahoo Finance)

Page 1 of 4

previousnext